About Tempero Bio
Tempero Bio is a company based in Oakland (United States) founded in 2020 by Ricardo Dolmetsch.. Tempero Bio has raised $70 million across 1 funding round from investors including Khosla Ventures, 8VC and Aditum Bio. Tempero Bio offers products and services including TMP-301. Tempero Bio operates in a competitive market with competitors including IgGenix, Mithradote Bio, Globin Solutions, metaLead Therapeutics and Sobrera, among others.
- Headquarter Oakland, United States
- Founders Ricardo Dolmetsch
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$70 M (USD)
in 1 rounds
-
Latest Funding Round
$70 M (USD), Series B
Mar 24, 2025
-
Investors
Khosla Ventures
& 2 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Tempero Bio
Tempero Bio offers a comprehensive portfolio of products and services, including TMP-301. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Drug for treating substance use disorders like CUD and AUD
Funding Insights of Tempero Bio
Tempero Bio has successfully raised a total of $70M through 1 strategic funding round. The most recent funding activity was a Series B round of $70 million completed in March 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $70.0M
-
First Round
First Round
(24 Mar 2025)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2025 | Amount | Series B - Tempero Bio | Valuation | 8VC |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Tempero Bio
Tempero Bio has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Khosla Ventures, 8VC and Aditum Bio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm investing in technology, life sciences, and related sectors.
|
Founded Year | Domain | Location | |
|
Early-stage startups are funded by this venture capital firm.
|
Founded Year | Domain | Location | |
|
Serves as a CRO specializing in Phase II clinical trials.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Tempero Bio
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Tempero Bio
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Tempero Bio Comparisons
Competitors of Tempero Bio
Tempero Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as IgGenix, Mithradote Bio, Globin Solutions, metaLead Therapeutics and Sobrera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutic solutions for food allergies are developed via antibody platforms.
|
|
| domain | founded_year | HQ Location |
Medication is provided to prevent drug-facilitated sexual assault.
|
|
| domain | founded_year | HQ Location |
Antidotal therapies for human poisonings are developed using neuroglobin technology.
|
|
| domain | founded_year | HQ Location |
Next-generation medications against metal poisoning are developed.
|
|
| domain | founded_year | HQ Location |
Drugs for alcohol use disorders are developed by Sobrera.
|
|
| domain | founded_year | HQ Location |
Develops innovative technologies for nicotine addiction treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Tempero Bio
Frequently Asked Questions about Tempero Bio
When was Tempero Bio founded?
Tempero Bio was founded in 2020 and raised its 1st funding round 5 years after it was founded.
Where is Tempero Bio located?
Tempero Bio is headquartered in Oakland, United States. It is registered at Oakland, California, United States.
Is Tempero Bio a funded company?
Tempero Bio is a funded company, having raised a total of $70M across 1 funding round to date. The company's 1st funding round was a Series B of $70M, raised on Mar 24, 2025.
What does Tempero Bio do?
Tempero Bio was founded in 2020 and is based in Oakland, United States, within the biotechnology sector focused on substance use disorders. Treatments for opioid use disorders and related conditions are developed by the company. The lead candidate, TMP-301, is investigated as an orally available metabotropic glutamate receptor 5 negative allosteric modulator for cocaine use disorder and alcohol use disorder. Operations center on advancing these therapeutics through clinical investigation.
Who are the top competitors of Tempero Bio?
Tempero Bio's top competitors include IgGenix, Mithradote Bio and Globin Solutions.
What products or services does Tempero Bio offer?
Tempero Bio offers TMP-301.
Who are Tempero Bio's investors?
Tempero Bio has 3 investors. Key investors include Khosla Ventures, 8VC, and Aditum Bio.